Cargando…
Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer
BACKGROUND: Lung cancer is the leading malignant disease and cause of cancer-related death worldwide. Most patients with lung cancer had insignificant early symptoms so that most of them were diagnosed at an advanced stage. In addition to factors such as smoking, pollution, lung microbiome and its m...
Autores principales: | Liu, Bo, Li, Yige, Suo, Lijun, Zhang, Wei, Cao, Hongyun, Wang, Ruicai, Luan, Jiahui, Yu, Xiaofeng, Dong, Liang, Wang, Wenjing, Xu, Shiyang, Lu, Shiyong, Shi, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705781/ https://www.ncbi.nlm.nih.gov/pubmed/36457513 http://dx.doi.org/10.3389/fonc.2022.1058436 |
Ejemplares similares
-
Metabolomic Analyses to Identify Candidate Biomarkers of Cystinosis
por: Nemutlu, Emirhan, et al.
Publicado: (2023) -
Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer
por: Liu, Chang, et al.
Publicado: (2022) -
Quantitative Proteomic Analysis of Plasma Exosomes to Identify the Candidate Biomarker of Imatinib Resistance in Chronic Myeloid Leukemia Patients
por: Li, Mei-Yong, et al.
Publicado: (2021) -
Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
por: Chen, Yingji, et al.
Publicado: (2021) -
Integrative Analysis of Metabolomics and Transcriptomics Data Identifies Prognostic Biomarkers Associated With Oral Squamous Cell Carcinoma
por: Zuo, Lihua, et al.
Publicado: (2021)